The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Lidocaine Transdermal Patch Market Research Report 2025
Synopsis
Lidocaine is chemically known as acetamide, 2- (diethylamino) -n - (2, 6-dimethyl phenyl), octanol at pH 7.4;Moisture ratio for 43, lidocaine transdermal patch is suitable for adults and adolescents 12 years of age or temporary pain relief including 5% lidocaine transdermal patches, 1.8% lidocaine transdermal patches, 4% lidocaine transdermal patches containing 5%, 1.8% and 4% respectively of lidocaine adhesive materials, the material paste on nonwoven polyester felt backing, and covered with polyethylene terephthalate (PET) film stripping gasket, before the break on the skin, to remove off lining.
The global Lidocaine Transdermal Patch market was valued at US$ 203.8 million in 2023 and is anticipated to reach US$ 249.9 million by 2030, witnessing a CAGR of 3.0% during the forecast period 2024-2030.
North American market for Lidocaine Transdermal Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lidocaine Transdermal Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Lidocaine Transdermal Patch include Teikoku, Teva Pharmaceutical, Sorrento Therapeutics, Hisamitsu, Endo International, Par Pharmaceutical, Mylan and Tide Pharmaceutical (SINO BIOPHARM), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lidocaine Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lidocaine Transdermal Patch.
Report Scope
The Lidocaine Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lidocaine Transdermal Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lidocaine Transdermal Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teikoku
Teva Pharmaceutical
Sorrento Therapeutics
Hisamitsu
Endo International
Par Pharmaceutical
Mylan
Tide Pharmaceutical (SINO BIOPHARM)
Segment by Type
Lidocare 5% Transdermal Patch
Lidocare 1.80% Transdermal Patch
Lidocare 4% Transdermal Patch
Segment by Application
Online Pharmacies
Hospital Pharmacies
Clinic
Monomer Pharmacies
Chain Pharmacies
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lidocaine Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lidocaine Transdermal Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Lidocaine is chemically known as acetamide, 2- (diethylamino) -n - (2, 6-dimethyl phenyl), octanol at pH 7.4;Moisture ratio for 43, lidocaine transdermal patch is suitable for adults and adolescents 12 years of age or temporary pain relief including 5% lidocaine transdermal patches, 1.8% lidocaine transdermal patches, 4% lidocaine transdermal patches containing 5%, 1.8% and 4% respectively of lidocaine adhesive materials, the material paste on nonwoven polyester felt backing, and covered with polyethylene terephthalate (PET) film stripping gasket, before the break on the skin, to remove off lining.
The global Lidocaine Transdermal Patch market was valued at US$ 203.8 million in 2023 and is anticipated to reach US$ 249.9 million by 2030, witnessing a CAGR of 3.0% during the forecast period 2024-2030.
North American market for Lidocaine Transdermal Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lidocaine Transdermal Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Lidocaine Transdermal Patch include Teikoku, Teva Pharmaceutical, Sorrento Therapeutics, Hisamitsu, Endo International, Par Pharmaceutical, Mylan and Tide Pharmaceutical (SINO BIOPHARM), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lidocaine Transdermal Patch, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lidocaine Transdermal Patch.
Report Scope
The Lidocaine Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (M Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lidocaine Transdermal Patch market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lidocaine Transdermal Patch manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teikoku
Teva Pharmaceutical
Sorrento Therapeutics
Hisamitsu
Endo International
Par Pharmaceutical
Mylan
Tide Pharmaceutical (SINO BIOPHARM)
Segment by Type
Lidocare 5% Transdermal Patch
Lidocare 1.80% Transdermal Patch
Lidocare 4% Transdermal Patch
Segment by Application
Online Pharmacies
Hospital Pharmacies
Clinic
Monomer Pharmacies
Chain Pharmacies
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lidocaine Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lidocaine Transdermal Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Lidocaine Transdermal Patch Market Overview
1.1 Product Overview and Scope of Lidocaine Transdermal Patch
1.2 Lidocaine Transdermal Patch Segment by Type
1.2.1 Global Lidocaine Transdermal Patch Market Value Comparison by Type (2024-2030)
1.2.2 Lidocare 5% Transdermal Patch
1.2.3 Lidocare 1.80% Transdermal Patch
1.2.4 Lidocare 4% Transdermal Patch
1.3 Lidocaine Transdermal Patch Segment by Application
1.3.1 Global Lidocaine Transdermal Patch Market Value by Application: (2024-2030)
1.3.2 Online Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Clinic
1.3.5 Monomer Pharmacies
1.3.6 Chain Pharmacies
1.3.7 Other
1.4 Global Lidocaine Transdermal Patch Market Size Estimates and Forecasts
1.4.1 Global Lidocaine Transdermal Patch Revenue 2019-2030
1.4.2 Global Lidocaine Transdermal Patch Sales 2019-2030
1.4.3 Global Lidocaine Transdermal Patch Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Lidocaine Transdermal Patch Market Competition by Manufacturers
2.1 Global Lidocaine Transdermal Patch Sales Market Share by Manufacturers (2019-2024)
2.2 Global Lidocaine Transdermal Patch Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Lidocaine Transdermal Patch Average Price by Manufacturers (2019-2024)
2.4 Global Lidocaine Transdermal Patch Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lidocaine Transdermal Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lidocaine Transdermal Patch, Product Type & Application
2.7 Lidocaine Transdermal Patch Market Competitive Situation and Trends
2.7.1 Lidocaine Transdermal Patch Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lidocaine Transdermal Patch Players Market Share by Revenue
2.7.3 Global Lidocaine Transdermal Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lidocaine Transdermal Patch Retrospective Market Scenario by Region
3.1 Global Lidocaine Transdermal Patch Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Lidocaine Transdermal Patch Global Lidocaine Transdermal Patch Sales by Region: 2019-2030
3.2.1 Global Lidocaine Transdermal Patch Sales by Region: 2019-2024
3.2.2 Global Lidocaine Transdermal Patch Sales by Region: 2025-2030
3.3 Global Lidocaine Transdermal Patch Global Lidocaine Transdermal Patch Revenue by Region: 2019-2030
3.3.1 Global Lidocaine Transdermal Patch Revenue by Region: 2019-2024
3.3.2 Global Lidocaine Transdermal Patch Revenue by Region: 2025-2030
3.4 North America Lidocaine Transdermal Patch Market Facts & Figures by Country
3.4.1 North America Lidocaine Transdermal Patch Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Lidocaine Transdermal Patch Sales by Country (2019-2030)
3.4.3 North America Lidocaine Transdermal Patch Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Lidocaine Transdermal Patch Market Facts & Figures by Country
3.5.1 Europe Lidocaine Transdermal Patch Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Lidocaine Transdermal Patch Sales by Country (2019-2030)
3.5.3 Europe Lidocaine Transdermal Patch Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lidocaine Transdermal Patch Market Facts & Figures by Country
3.6.1 Asia Pacific Lidocaine Transdermal Patch Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Lidocaine Transdermal Patch Sales by Country (2019-2030)
3.6.3 Asia Pacific Lidocaine Transdermal Patch Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Lidocaine Transdermal Patch Market Facts & Figures by Country
3.7.1 Latin America Lidocaine Transdermal Patch Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Lidocaine Transdermal Patch Sales by Country (2019-2030)
3.7.3 Latin America Lidocaine Transdermal Patch Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lidocaine Transdermal Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Lidocaine Transdermal Patch Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Lidocaine Transdermal Patch Sales by Country (2019-2030)
3.8.3 Middle East and Africa Lidocaine Transdermal Patch Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Lidocaine Transdermal Patch Sales by Type (2019-2030)
4.1.1 Global Lidocaine Transdermal Patch Sales by Type (2019-2024)
4.1.2 Global Lidocaine Transdermal Patch Sales by Type (2025-2030)
4.1.3 Global Lidocaine Transdermal Patch Sales Market Share by Type (2019-2030)
4.2 Global Lidocaine Transdermal Patch Revenue by Type (2019-2030)
4.2.1 Global Lidocaine Transdermal Patch Revenue by Type (2019-2024)
4.2.2 Global Lidocaine Transdermal Patch Revenue by Type (2025-2030)
4.2.3 Global Lidocaine Transdermal Patch Revenue Market Share by Type (2019-2030)
4.3 Global Lidocaine Transdermal Patch Price by Type (2019-2030)
5 Segment by Application
5.1 Global Lidocaine Transdermal Patch Sales by Application (2019-2030)
5.1.1 Global Lidocaine Transdermal Patch Sales by Application (2019-2024)
5.1.2 Global Lidocaine Transdermal Patch Sales by Application (2025-2030)
5.1.3 Global Lidocaine Transdermal Patch Sales Market Share by Application (2019-2030)
5.2 Global Lidocaine Transdermal Patch Revenue by Application (2019-2030)
5.2.1 Global Lidocaine Transdermal Patch Revenue by Application (2019-2024)
5.2.2 Global Lidocaine Transdermal Patch Revenue by Application (2025-2030)
5.2.3 Global Lidocaine Transdermal Patch Revenue Market Share by Application (2019-2030)
5.3 Global Lidocaine Transdermal Patch Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teikoku
6.1.1 Teikoku Corporation Information
6.1.2 Teikoku Description and Business Overview
6.1.3 Teikoku Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teikoku Lidocaine Transdermal Patch Product Portfolio
6.1.5 Teikoku Recent Developments/Updates
6.2 Teva Pharmaceutical
6.2.1 Teva Pharmaceutical Corporation Information
6.2.2 Teva Pharmaceutical Description and Business Overview
6.2.3 Teva Pharmaceutical Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharmaceutical Lidocaine Transdermal Patch Product Portfolio
6.2.5 Teva Pharmaceutical Recent Developments/Updates
6.3 Sorrento Therapeutics
6.3.1 Sorrento Therapeutics Corporation Information
6.3.2 Sorrento Therapeutics Description and Business Overview
6.3.3 Sorrento Therapeutics Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sorrento Therapeutics Lidocaine Transdermal Patch Product Portfolio
6.3.5 Sorrento Therapeutics Recent Developments/Updates
6.4 Hisamitsu
6.4.1 Hisamitsu Corporation Information
6.4.2 Hisamitsu Description and Business Overview
6.4.3 Hisamitsu Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hisamitsu Lidocaine Transdermal Patch Product Portfolio
6.4.5 Hisamitsu Recent Developments/Updates
6.5 Endo International
6.5.1 Endo International Corporation Information
6.5.2 Endo International Description and Business Overview
6.5.3 Endo International Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Endo International Lidocaine Transdermal Patch Product Portfolio
6.5.5 Endo International Recent Developments/Updates
6.6 Par Pharmaceutical
6.6.1 Par Pharmaceutical Corporation Information
6.6.2 Par Pharmaceutical Description and Business Overview
6.6.3 Par Pharmaceutical Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Par Pharmaceutical Lidocaine Transdermal Patch Product Portfolio
6.6.5 Par Pharmaceutical Recent Developments/Updates
6.7 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan Lidocaine Transdermal Patch Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Tide Pharmaceutical (SINO BIOPHARM)
6.8.1 Tide Pharmaceutical (SINO BIOPHARM) Corporation Information
6.8.2 Tide Pharmaceutical (SINO BIOPHARM) Description and Business Overview
6.8.3 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Tide Pharmaceutical (SINO BIOPHARM) Lidocaine Transdermal Patch Product Portfolio
6.8.5 Tide Pharmaceutical (SINO BIOPHARM) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lidocaine Transdermal Patch Industry Chain Analysis
7.2 Lidocaine Transdermal Patch Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lidocaine Transdermal Patch Production Mode & Process
7.4 Lidocaine Transdermal Patch Sales and Marketing
7.4.1 Lidocaine Transdermal Patch Sales Channels
7.4.2 Lidocaine Transdermal Patch Distributors
7.5 Lidocaine Transdermal Patch Customers
8 Lidocaine Transdermal Patch Market Dynamics
8.1 Lidocaine Transdermal Patch Industry Trends
8.2 Lidocaine Transdermal Patch Market Drivers
8.3 Lidocaine Transdermal Patch Market Challenges
8.4 Lidocaine Transdermal Patch Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
